<DOC>
	<DOCNO>NCT00467883</DOCNO>
	<brief_summary>Evaluation 4 week treatment end treatment occur . Efficacy define objective response ; complete partial response .</brief_summary>
	<brief_title>Pilot Study High Dose Liposomal Amphotericin B Efficacy Initial Zygomycosis Treatment</brief_title>
	<detailed_description>Primary objective : Efficacy 4 week liposomal amphotericin B ( AmBisome® ) high dose [ 10 mg/kg/j ] maximal tolerable dose initial zygomycosis treatment . Evaluation 4 week treatment end treatment occur . Efficacy define objective response ; complete partial response . Secondary objective : Efficacy , tolerance survival 15 day treatment , cumulative dose AmBisome® necessary obtain objective response , efficacy operate non operated patient , tolerance 4 12 week treatment , survival , relapse rate 6 month 4 week liposomal amphotericin B ( AmBisome® ) high dose [ 10 mg/kg/j ] maximal tolerable dose . Scheme : prospective , multicentric , non comparative therapeutic pilot study . Inclusion criterion : Presence tissue biopsy large non septated hypha compatible zygomycete presence zygomycete culture associate clinical radiological abnormality compatible fungal invasive infection . Exclusion criterion : Life expectancy 72 hour , pregnancy , breast feeding , polyene hypersensitivity , absence histologic mycologic zygomycosis documentation , absence inform consent , previous treatment polyene antifungal active zygomycete ( posaconazole , itraconazole ) 5 day month previous inclusion . Treatment : AmBisome® 10 mg/kg/j monotherapy least 15 day , AmBisome® maximal tolerable dose 15 day associate early optimal surgical treatment . After first treatment month , follow treatment decide referent physician .</detailed_description>
	<mesh_term>Zygomycosis</mesh_term>
	<mesh_term>Mucormycosis</mesh_term>
	<mesh_term>Amphotericin B</mesh_term>
	<mesh_term>Liposomal amphotericin B</mesh_term>
	<criteria>Presence tissue biopsy large non septated hypha compatible zygomycete Presence zygomycete culture associate clinical radiological abnormality compatible fungal invasive infection . Life expectancy 72 hour , Pregnancy , breast feeding , Polyene hypersensitivity , Absence histologic mycologic zygomycosis documentation , Absence inform consent , Previous treatment polyene antifungal active zygomycete ( posaconazole , itraconazole ) 5 day month previous inclusion</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Zygomycosis</keyword>
	<keyword>High dose liposomal amphotericin B</keyword>
</DOC>